|
TOP3A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.884280E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.078100E-03 |
| Normal-vs-Stage2 |
1.230400E-01 |
| Normal-vs-Stage3 |
1.177320E-03 |
| Normal-vs-Stage4 |
7.942400E-03 |
| Stage1-vs-Stage2 |
4.621600E-01 |
| Stage1-vs-Stage3 |
2.205200E-01 |
| Stage1-vs-Stage4 |
4.218200E-01 |
| Stage2-vs-Stage3 |
1.472370E-01 |
| Stage2-vs-Stage4 |
2.514200E-01 |
| Stage3-vs-Stage4 |
9.158000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.782780E-03 |
| Normal-vs-AfricanAmerican |
7.926300E-02 |
| Normal-vs-Asian |
4.795600E-01 |
| Caucasian-vs-AfricanAmerican |
7.775200E-01 |
| Caucasian-vs-Asian |
4.306000E-02 |
| AfricanAmerican-vs-Asian |
2.879600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.337500E-03 |
| Normal-vs-Female |
3.522000E-03 |
| Male-vs-Female |
5.516200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.939670E-02 |
| Normal-vs-Age(41-60Yrs) |
1.436010E-03 |
| Normal-vs-Age(61-80Yrs) |
7.315700E-03 |
| Normal-vs-Age(81-100Yrs) |
8.278200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.887250E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.154200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.665200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.314000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.722000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.268600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.400300E-03 |
| Classical-VS-Follicular |
2.031800E-02 |
| Classical-VS-Other |
1.000180E-01 |
| Classical-VS-Normal |
2.745800E-02 |
| Tall-VS-Follicular |
3.364800E-01 |
| Tall-VS-Other |
7.964600E-01 |
| Tall-VS-Normal |
4.577100E-04 |
| Follicular-VS-Other |
4.398600E-01 |
| Follicular-VS-Normal |
1.078160E-03 |
| Other-VS-Normal |
2.646300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.184300E-03 |
| Normal-vs-N1 |
8.822700E-04 |
| N0-vs-N1 |
1.152440E-01 |
|
|
